Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-11-15 Purchase | 2019-11-19 9:47 pm | NextCure Inc. | NXTC | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 150,000 | $36.75 | $5,512,500 | 2,671,856 (Direct) | View |
| 2019-11-12 Purchase | 2019-11-12 4:17 pm | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 750,000 | $12 | $9,000,000 | 3,083,712 (Direct) | View |
| 2019-05-13 Purchase | 2019-05-15 5:59 pm | NextCure Inc. | NXTC | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 400,000 | $15 | $6,000,000 | 2,521,856 (Direct) | View |
| 2018-10-22 Purchase | 2018-10-23 7:13 pm | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 372,093 | $10.75 | $4,000,000 | 1,911,573 (Indirect) | View |
| 2018-09-28 Purchase | 2018-10-02 9:41 pm | Entasis Therapeutics Holdings Inc. | ETTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 337,724 | $15 | $5,065,860 | 1,180,178 (Direct) | View |
| 2018-09-18 Purchase | 2018-09-20 7:02 pm | Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner | 270,000 | $17 | $4,590,000 | 2,059,146 (Direct) | View |
| 2018-05-30 Purchase | 2018-05-30 9:59 pm | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. POWELL MICHAEL Sofinnova Management IX L.L.C. Mehra Anand 10% Owner | 500,000 | $13 | $6,500,000 | 1,726,514 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-02 Option Award | 2022-06-06 5:21 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 20,257 | $0 | 54,454 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-06 5:21 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 3,356 | $0 | 54,454 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:06 pm | N/A 2032-05-31 | Merus N.V. | MRUS | Mehra Anand Director | 16,604 | $0 | 16,604 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 8:00 pm | N/A 2031-06-02 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 15,606 | $0 | 15,606 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 4:10 pm | N/A 2031-05-28 | Merus N.V. | MRUS | Mehra Anand Director | 6,120 | $0 | 6,120 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-03 5:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 6,632 | $18.32 | 30,841 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-03 5:33 pm | N/A 2028-06-06 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 14,632 | $0 | 30,841 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-03 5:33 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,000 | $18.35 | 30,841 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-02 4:00 pm | N/A 2030-06-30 | Merus N.V. | MRUS | Mehra Anand Director | 8,631 | $0 | 8,631 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:30 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 16,500 | $0 | 32,709 (Direct) | View |
| 2020-06-06 Exercise | 2020-06-08 5:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 7,333 | $0 | 32,709 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,876 | $0 | 17,752 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:25 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,876 | $0 | 17,752 (Direct) | View |
Ownership | 2020-01-02 09:00 am | N/A N/A | Merus N.V. | MRUS | Mehra Anand Director | 0 | $0 | 1,997,172 (Indirect) | View |
| 2019-12-17 Disposition | 2019-12-17 4:47 pm | N/A 2028-05-29 | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 14,000 | $0 | 0 (Direct) | View |
| 2019-12-17 Equity Swap | 2019-12-17 4:47 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 521,473 | $114.5 | 0 (Direct) | View |
| 2019-11-12 Conversion | 2019-11-12 4:17 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 14,134,280 | $0 | 3,083,712 (Direct) | View |
Ownership | 2019-11-06 5:22 pm | N/A N/A | Galera Therapeutics Inc. | GRTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 0 | $0 | 2,333,712 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 5:47 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 7,333 | $0 | 7,333 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 5:41 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 1,500 | $0 | 521,473 (Direct) | View |
| 2019-05-13 Conversion | 2019-05-15 5:59 pm | N/A N/A | NextCure Inc. | NXTC | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 19,168,441 | $0 | 2,521,856 (Direct) | View |
Ownership | 2019-05-08 9:04 pm | N/A N/A | NextCure Inc. | NXTC | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner | 0 | $0 | 2,121,856 (Direct) | View |
| 2019-01-04 Exercise | 2019-01-08 4:30 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 37,203 | $3.45 | 519,973 (Direct) | View |
| 2019-01-04 Exercise | 2019-01-08 4:30 pm | N/A 2024-08-11 | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 37,203 | $0 | 519,973 (Direct) | View |
| 2018-09-28 Conversion | 2018-10-02 9:41 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 17,766,845 | $0 | 1,180,178 (Direct) | View |
Ownership | 2018-09-25 8:50 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Mehra Anand POWELL MICHAEL 10% Owner | 0 | $0 | 16,949,153 (Direct) | View |
| 2018-09-18 Conversion | 2018-09-20 7:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner | 1,768,208 | $0 | 2,059,146 (Direct) | View |
Ownership | 2018-09-13 5:10 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES POWELL MICHAEL Mehra Anand 10% Owner | 0 | $0 | 1,789,146 (Direct) | View |
| 2018-06-07 Option Award | 2018-06-08 4:00 pm | N/A 2028-06-06 | Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2018-05-30 Option Award | 2018-06-01 4:03 pm | N/A 2028-05-29 | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 5,500 | $0 | 488,270 (Direct) | View |
| 2018-05-31 Exercise | 2018-06-01 4:03 pm | N/A N/A | Spark Therapeutics Inc. | ONCE | Mehra Anand Director | 1,500 | $0 | 488,270 (Direct) | View |
| 2018-05-30 Conversion | 2018-05-30 9:59 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. POWELL MICHAEL Sofinnova Management IX L.L.C. Mehra Anand 10% Owner | 1,226,514 | $0 | 1,726,514 (Direct) | View |
Ownership | 2018-05-24 6:31 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. POWELL MICHAEL Sofinnova Management IX L.L.C. Mehra Anand 10% Owner | 0 | $0 | 1,226,514 (Direct) | View |